Expanding Active Surveillance Criteria for Low- and Intermediate-risk Prostate Cancer: Can We Accurately Predict the Risk of Misclassification for Patients Diagnosed by Multiparametric Magnetic Resonance Imaging–targeted Biopsy?
Author:
Romain Diamand,Simone Albisinni,Jean-Baptiste Roche,Elena Lievore,Vito Lacetera,Giuseppe Chiacchio,Valerio Beatrici,Riccardo Mastroianni,Giuseppe Simone,Olivier Windisch,Daniel Benamran,Alexandre Fourcade,Truong An Nguyen,Georges Fournier et al.
Publication:
European Urology Focus
© 2022 European Association of Urology. Published by Elsevier B.V. All rights reserved.